PRIMABS
Live / Applied — Second extension granted (statement of use) (as of 07 Jan 2026)
What this means for you
Not registered yet, but its 26 Oct 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97092356
- Mark type
- Stylized text
- Filed
- 26 Oct 2021
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Jeffrey Joyce
Goods and services
- Class 005 — Pharmaceuticals: Predictive diagnostic anti body biomarker reagents for medical purposes, namely, for predictive diagnosis of cancer and immune disease
Owner
- EUTROPICS PHARMACEUTICALS, INC., Cambridge, MA, US
- EUTROPICS PHARMACEUTICALS, INC., Cambridge, MA, US
Prosecution history
- 07 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2026 — SOU EXTENSION 2 GRANTED
- 07 Jan 2026 — SOU EXTENSION 2 FILED
- 07 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jul 2025 — SOU EXTENSION 1 GRANTED
- 03 Jul 2025 — SOU EXTENSION 1 FILED
- 03 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Jan 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Jan 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION
- 20 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED